NO20073333L - Nye farmasoytiske sammensetninger for vaksiner - Google Patents

Nye farmasoytiske sammensetninger for vaksiner

Info

Publication number
NO20073333L
NO20073333L NO20073333A NO20073333A NO20073333L NO 20073333 L NO20073333 L NO 20073333L NO 20073333 A NO20073333 A NO 20073333A NO 20073333 A NO20073333 A NO 20073333A NO 20073333 L NO20073333 L NO 20073333L
Authority
NO
Norway
Prior art keywords
vaccines
pharmaceutical compositions
new pharmaceutical
vaccine
relates
Prior art date
Application number
NO20073333A
Other languages
English (en)
Norwegian (no)
Inventor
Marinette Moreau
Nicolas Osty
Original Assignee
Vetoquinol Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vetoquinol Sa filed Critical Vetoquinol Sa
Publication of NO20073333L publication Critical patent/NO20073333L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
NO20073333A 2004-12-02 2007-06-28 Nye farmasoytiske sammensetninger for vaksiner NO20073333L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0452838A FR2878746B1 (fr) 2004-12-02 2004-12-02 Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins
PCT/FR2005/002995 WO2006059009A1 (fr) 2004-12-02 2005-12-01 Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins

Publications (1)

Publication Number Publication Date
NO20073333L true NO20073333L (no) 2007-08-17

Family

ID=34952132

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073333A NO20073333L (no) 2004-12-02 2007-06-28 Nye farmasoytiske sammensetninger for vaksiner

Country Status (17)

Country Link
US (1) US8158133B2 (ja)
EP (1) EP1817053A1 (ja)
JP (1) JP4987725B2 (ja)
KR (1) KR20070106988A (ja)
CN (1) CN101111262A (ja)
AU (1) AU2005311188B2 (ja)
BR (1) BRPI0517124A (ja)
CA (1) CA2589841A1 (ja)
EA (1) EA200701201A1 (ja)
FR (1) FR2878746B1 (ja)
IL (1) IL183518A (ja)
MX (1) MX2007006521A (ja)
NO (1) NO20073333L (ja)
NZ (1) NZ555743A (ja)
UA (1) UA91203C2 (ja)
WO (1) WO2006059009A1 (ja)
ZA (1) ZA200705079B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2851066A1 (en) * 2013-09-23 2015-03-25 LTS LOHMANN Therapie-Systeme AG Fixation of vaccine formulations on devices for epidermal immunisation by oily adjuvants

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US478056A (en) * 1892-06-28 Trustees
ZA872532B (en) 1986-04-21 1987-11-25 Akzo Nv Combined vaccine
EP0296661B1 (en) * 1987-06-23 1992-01-22 ENIRICERCHE S.p.A. Single-phase composition containing a perfluorinated oil and one or more surfactant(s), useful as an excipient for cosmetic and dermatologic formulations, as well as for biomedical applications
AU643210B2 (en) 1989-05-16 1993-11-11 Medice Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg Process for preparing optically active 2-aryl-alkanoic acids, in particular 2-ayrl-propionic acids
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
US5744137A (en) * 1995-02-06 1998-04-28 The United States Of America As Represented By The Secretary Of The Agriculture Oil emulsion vaccines prepared with animal, vegetable, and synthetic oils using a mixture of nonionic surfactants
JP4104186B2 (ja) * 1995-11-30 2008-06-18 財団法人化学及血清療法研究所 オイルアジュバントワクチンおよびその調製方法
ATE353225T1 (de) * 1995-11-30 2007-02-15 Chemo Sero Therapeut Res Inst Öladjuvierter impfstoff und verfahren zu seiner herstellung
EP0988858A1 (en) * 1997-04-18 2000-03-29 Taisho Pharmaceutical Co., Ltd Microemulsion
WO1999060012A1 (en) * 1998-05-21 1999-11-25 Isis Pharmaceuticals, Inc. Compositions and methods for non-parenteral delivery of oligonucleotides
US6919442B1 (en) * 1998-05-22 2005-07-19 The United States Of America As Represented By The Department Of Health And Human Services Nucleic acids comprising a post-transcriptional regulatory element (PRE) and their uses
RU2202340C2 (ru) 1998-05-27 2003-04-20 Юроселтик С.А. Система доставки лекарства
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
JP4570705B2 (ja) 1999-03-04 2010-10-27 株式会社資生堂 メーキャップ除去用化粧料
JP4642950B2 (ja) 1999-03-04 2011-03-02 株式会社資生堂 メーキャップ除去用化粧料
EP1104767A1 (en) 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
ES2260291T3 (es) 2000-09-28 2006-11-01 Chiron Corporation Microparticulas para la administracion de acidos nucleicos heterologos.
WO2002067899A1 (en) * 2001-02-28 2002-09-06 Akzo Nobel N.V. Injectable water-in-oil emulsions
SK15762003A3 (sk) 2001-06-29 2005-01-03 Chiron Corporation Kompozícia vakcíny HCV E1E2
US20030119774A1 (en) * 2001-09-25 2003-06-26 Marianna Foldvari Compositions and methods for stimulating an immune response
AU2004226591B2 (en) * 2003-04-04 2009-06-04 Zoetis Services Llc Microfluidized oil-in-water emulsions and vaccine compositions
DE602004014624D1 (de) * 2003-08-29 2008-08-07 Yissum Res Dev Co Selbst-nanoemulgierende ölige formulierung zur verabreichung von schwer wasserlöslichen arzneimitteln

Also Published As

Publication number Publication date
AU2005311188B2 (en) 2011-07-07
MX2007006521A (es) 2007-11-08
ZA200705079B (en) 2008-08-27
IL183518A0 (en) 2007-09-20
WO2006059009A1 (fr) 2006-06-08
UA91203C2 (ru) 2010-07-12
CN101111262A (zh) 2008-01-23
JP2008521865A (ja) 2008-06-26
NZ555743A (en) 2009-06-26
EP1817053A1 (fr) 2007-08-15
BRPI0517124A (pt) 2008-09-30
KR20070106988A (ko) 2007-11-06
US8158133B2 (en) 2012-04-17
JP4987725B2 (ja) 2012-07-25
AU2005311188A1 (en) 2006-06-08
US20080026006A1 (en) 2008-01-31
CA2589841A1 (fr) 2006-06-08
FR2878746A1 (fr) 2006-06-09
IL183518A (en) 2011-09-27
EA200701201A1 (ru) 2007-10-26
FR2878746B1 (fr) 2007-02-23

Similar Documents

Publication Publication Date Title
WO2017070620A3 (en) Broad spectrum influenza virus vaccine
MX2010008799A (es) Proceso para estabilizar una composicion de vacuna que contiene adyuvante.
WO2010019262A3 (en) Polyvalent vaccine
NO20091395L (no) Nye tiofenderivater
BR112012029517A2 (pt) formulações de fragrância, métodos de fabricação e artigos compreendendo as mesmas.
CY1118454T1 (el) Πρωτοτυποι αναστολεις πυρρολιου της αναγωγασης s-νιτροζογλουταθειονης ως θεραπευτικοι παραγοντες
EA201070699A1 (ru) Композиции 3-(6-(1-2,2-дифторбензо[d][1,3]диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты
EA201170772A1 (ru) Органические соединения
CY1115838T1 (el) Μεθοδος για τη σταθεροποιηση φαρμακοτεχνικων μορφων που περιεχουν μικροοργανισμους
NO20084850L (no) MGLUR5 modulatorer I
MX2010007587A (es) Compuestos que comprenden un grupo ciclobutoxi.
PH12013502442A1 (en) Inactivated dengue virus vaccine
CY1111367T1 (el) Νεα παραγωγα της διοσμετινης, η μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα περιεχουν
WO2011091376A3 (en) Immunogenic influenza composition
EA201070689A1 (ru) Композиция для личного ухода
HK1248069A1 (zh) 去乙酰氧基微管溶素h及其类似物
WO2009009759A3 (en) Yersinia pestis antigens, vaccine compositions, and related methods
MX349156B (es) Formas cristalinas y procesos para la preparacion de fenil-pirazoles utiles como moduladores del receptor de serotonina 5-ht2a.
ATE482194T1 (de) Indolonderivate, verfahren zu deren herstellung und deren anwendungen
MY151211A (en) 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
BRPI0909737A2 (pt) compostos de pirrolidinila, composição farmacêutica compreendendo os mesmos e usos dos mesmos
NO20091990L (no) Substituerte pyrazoler, sammensetninger inneholdende disse, fremgangsmate for fremstilling og anvendelse
DK1810676T3 (da) Levetiracetam formuleringer og fremgangsmåder til deres fremstilling
MX349563B (es) Formulacion farmaceutica de fenofibrato nanonizado.
NO20073333L (no) Nye farmasoytiske sammensetninger for vaksiner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application